IQVIA Laboratories Genomics is the first to validate Illumina's TruSight Oncology Comprehensive (EU) CE-IVD assay

IQVIA Laboratories Genomics is a leading provider of innovative and reliable assays designed to support oncology clinical trials and precision medicine development. Our broad range of assays includes next-gen sequencing panels, gene expression assays, clonality analysis, RNA sequencing, ctDNA sequencing, single cell sequencing, spatial gene expression, and personalized cancer vaccine neoantigen sequencing.

Our groundbreaking achievements include being the first CRO to validate Illumina's TruSight Oncology Comprehensive (EU) CE-IVD assay, allowing us to offer IVDR-compliant prospective testing of European clinical trial patient tumor samples.

Additionally, we are the first and currently only global CRO offering Illumina's TSO500 family of assays to support prospective testing of patient samples from clinical trials across Europe, US, and China.

Here are just a few reasons why you should choose us for your clinical trial needs:

• We are now offering TSO500 ctDNA v2 (validated to GCP level at our China and USA labs, for exploratory testing). This new version of the assay offers the same markers/content, but with both improved sensitivity and reduced sample input requirements over the original assay.
• Extensive experience with Illumina's oncology portfolio of assays since 2018, including TruSight Tumor 170, TSO 500 FFPE, TSO 500 ctDNA, and TSO Comp.
• The first CRO to validate Illumina's TruSight Oncology Comprehensive (EU) CE-IVD assay, allowing us to offer IVDR-compliant prospective testing of European clinical trial patient tumor samples.
• The first and only global CRO offering Illumina's TSO500 family of assays to support prospective testing of patient samples from clinical trials across Europe, US, and China.
• The first global CRO certified service provider of 10x Genomics FLEX FFPE single-cell RNA sequencing and 10x Genomics single-cell CITEseq.
• CAP-CLIA validated whole exome and RNA sequencing for rapid turnaround personalized cancer vaccine neoantigen sequencing.

IQVIA Laboratories Genomics offers dependable and inventive assays that support the progress of oncology clinical trials and precision medicine development.  Connect with us today to learn more about our innovative and reliable assays and how we can help you achieve your clinical trial goals.